Preparation of Cycloalkane-trans-1,2-diols
SCHEME 6
DAICEL-CHIRALPAK AD; eluent, 10% i-PrOH in hexane; flow
rate, 1.0 mL; detection, RI; retention time (tR): (()-3: tR ) 16
and 18 min, (R,R)-(-)-3: tR ) 18 min].
(S,S)-(+)-3,4-Dihydroxy-1,1-bis(methoxycarbonyl)cyclopen-
tane (3). Solvolysis of (-)-5 by treatment with K2CO3 in MeOH
afforded (S,S)-(+)-3 in quantitative yield. (S,S)-(+)-3: colorless
crystals; [R]31 +12.0 (c 1.00, CHCl3).
D
Kinetic Resolution of (()-8. Amano AK-catalyzed transesteri-
fication of (()-8 afforded monoacetate (+)-10 (51%, 95% ee) and
the diol (-)-8 (43%, >99% ee). (+)-10: a colorless oil; [R]26
D
Conclusion
+16.0 (c 1.04, CHCl3); IR (neat) 3468 (br), 1728 cm-1; H NMR
1
We synthesized the cycloalkane-trans-1,2-diols 3 and 8
bearing a diester moiety by using olefin metathesis with Grubbs
catalyst, followed by epoxidation and acidic hydrolysis. The
Amano PS-catalyzed kinetic resolution of racemic diol (()-3
by transesterification afforded the enantiomerically enriched
monoaceate (S,S)-(-)-5 (95% ee) in 46% yield and the diol
(R,R)-(-)-3 (92% ee) in 51% yield. Furthermore, the Amano
AK-catalyzed transesterification of the seven-membered-ring
(()-8 gave the highly enantiomerically enriched monoacetate
(S,S)-(+)-10 (>99% ee) and the diol (R,R)-(-)-8 (>99% ee),
by tuning the reaction conditions. It is noteworthy that the lipases
Amano PS and Amano AK took up the (S,S)-diols 3 and 8 in
their active site, but not the (R,R)-enantiomers. In the case of
the reported simple cycloalkane-1,2-diols, the active site of
Amano PS took up and acylated the opposite (R,R)-enantiomers.
To explain the influence of the diester moiety on the enantiomer
selectivity, we performed calculations for the lipase-substrate
complexes by using computer modeling. The calculation showed
that in the case of simple cyclopentane-1,2-diol, the (R,R)-
monoacetate-lipase complex was more stable than the (S,S)
complex, and in the case of cyclopentane-1,2-diol 3 having a
diester, the (S,S)-diol-lipase complex was more stable than the
(R,R) complex. These calculated results are in good agreement
with the experimental results. As an application of the optically
active 1,2-diol, we efficiently synthesized the chiral cyclic R,R-
disubstituted amino acid (4R,5R)-Ac7cdOM (-)-15, in which the
R-carbon atom is not an asymmetric center.
(400 MHz, CDCl3) δ 4.64 (m, 1H), 3.73 (s, 3H), 3.72 (s, 3H), 3.68
(m, 1H), 2.40 (br, 1H), 2.25-2.42 (m, 2H), 2.08 (s, 3H), 1.72-
2.05 (m, 4H), 1.64-1.76 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
172.5, 172.3, 171.1, 80.3, 74.8, 56.2, 52.6, 52.5, 27.9, 27.3, 27.1,
25.3, 21.2; FAB(+)HRMS calcd for C13H21O7 (M+ + H) 289.1287,
found 289.1294. Enantiomeric excess of monoacetate 10 was
determined by HPLC [column, DAICEL-CHIRALPAK AD; eluent,
10% i-PrOH in hexane; flow rate, 1.0 mL; detection, RI; retention
time: (()-10: tR ) 16 and 17 min, (+)-10: tR ) 17 min]. (R,R)-
(-)-8: colorless crystals; mp 59-61 °C; [R]26 -16.7 (c 1.01,
D
CHCl3). Enantiomeric excess of diol 8 was determined by HPLC
[column, TOSOH-BP developing column; eluent, 10% i-PrOH in
hexane; flow rate, 1.0 mL; detection, RI; retention time: (()-8:
tR ) 7 and 8 min, (-)-8: tR ) 8 min].
(S,S)-(+)-4,5-Dihydroxy-1,1-bis(methoxycarbonyl)cyclohep-
tane (8). Solvolysis of (+)-10 by treatment with K2CO3 in MeOH
afforded (S,S)-(+)-8 (quantitative). Colorless crystals; [R]31D +15.4
(c 1.05, CHCl3).
(4R,5R)-(-)-4,5-Dimethoxy-1,1-bis(methoxycarbonyl)cyclo-
heptane {(-)-14}. A suspension of (-)-8 (1.30 g, 5.28 mmol) and
Ag2O (24.5 g, 105 mmol) in MeI (30 mL) was vigorously stirred
and refluxed under an Ar atmosphere. After being stirred for 10
days, the Ag2O was filtered off, and the filtrate was concentrated
in vacuo to leave a solid, which was purified by column chroma-
tography on silica gel. The fraction eluted with 20% EtOAc in
hexane afforded (-)-14 (1.43 g, 99%) as colorless crystals. Mp
51-53 °C (from CHCl3/hexane); [R]24 -2.90 (c 1.23, CHCl3);
D
1
IR (KBr) 2952, 2823, 1733 cm-1; H NMR (400 MHz, CDCl3) δ
3.71 (s, 6H), 3.35 (s, 6H), 3.26 (m, 2H), 2.20 (m, 2H), 1.99 (m,
2H), 1.70-1.80 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 172.7,
82.7, 56.6, 56.5, 52.4, 25.9, 23.5; FAB(+)MS m/z 275 (M+ + H).
Anal. Calcd for C13H22O6: C, 56.92; H, 8.08. Found: C, 56.55; H,
7.92.
Experimental Section
Kinetic Resolution of (()-3 by Transesterification. A mixture
of diol (()-3 (100 mg, 0.459 mmol) and Amamo PS (100 mg) in
vinyl acetate (5 mL) was vigorously stirred at 40 °C for 72 h. The
lipase was filtered off, and the filtrate was evaporated in vacuo to
afford a residue, which was purified by column chromatography
on silica gel. The fraction eluted with 30% EtOAc in hexane
afforded monoacetate (-)-5 (44 mg, 37%, 95% ee), and that eluted
with EtOAc gave diol (-)-3 (56 mg, 56%, 66% ee). (-)-5: 95%
Methyl (4R,5R)-(-)-1-Benzyloxycarbonylamino-4,5-(dimethox-
y)cycloheptanecarboxylate [Cbz-{(R,R)-Ac7cdOM}-OMe; 15]. A
solution of (-)-14 (1.26 g, 4.60 mmol) in MeOH (50 mL) and 0.1
N aqueous NaOH solution (70 mL) was stirred overnight from at
0 °C to room temperature. The solution was acidified with 10%
aqueous HCl to pH 3-4, and then MeOH was evaporated. The
aqueous solution was extracted with EtOAc and dried over Na2-
SO4. Removal of the solvent afforded a crude monocarboxylic acid
that was used for the next reaction without purification. A solution
of the crude carboxylic acid, Et3N (700 mg, 6.90 mmol), and
diphenylphosphoryl azide (DPPA; 1.90 g, 6.90 mmol) in toluene
(20 mL) was refluxed for 1.5 h under an Ar atmosphere. Then,
benzyl alcohol (0.7 mL, 6.9 mmol) was added to the solution, and
the whole was refluxed for 3 days. After being cooled to room
temperature, the solution was diluted with EtOAc, washed with
2% aqueous HCl, 5% aqueous NaHCO3, and brine, and dried over
MgSO4. After removal of the solvent, the residue was purified by
column chromatography on silica gel (60% EtOAc in hexane) to
give (-)-15 (1.54 g, 92%) as a colorless oil. [R]24D -8.32 (c 1.04,
ee; a colorless oil; [R]24 -14.0 (c 1.00, CHCl3); IR (neat) 3507
D
(br), 1736 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.93 (m, 1H), 4.21
(m, 1H), 3.76 (s, 3H), 3.75 (s, 3H), 2.82 (dd, J ) 6.7, 15.0 Hz,
1H), 2.76 (br, 1H), 2.68 (dd, J ) 6.4, 14.4 Hz, 1H), 2.38 (dd, J )
4.5, 15.0 Hz, 1H), 2.78 (dd, J ) 4.3, 14.4 Hz, 1H), 2.04 (s, 3H);
13C NMR (100 MHz, CDCl3) δ 172.6, 171.7, 171.1, 81.1, 76.2,
57.6, 53.1, 52.9, 39.9, 37.4, 20.9; FAB(+)HRMS calcd for C11H17O7
(M+ + H) 261.0974, found 261.1024. (R,R)-(-)-3: 92% ee (entry
2); colorless crystals; mp 72-74 °C; [R]24D -11.2 (c 1.00, CHCl3).
Enantiomeric excess of diols 3 was determined by HPLC [column,
(16) (a) Shioiri, T.; Ninomiya, K.; Yamada, S. J. Am. Chem. Soc. 1972,
94, 6203-6205. (b) Ninomiya, K.; Shioiri, T.; Yamada, S. Tetrahedron
1974, 30, 2151-2157. (c) Evans, D. A.; Wu, L. D.; Wiener, J. J. M.;
Johnson, J. S.; Ripin, D. H. B.; Tedrow, J. S. J. Org. Chem. 1999, 64,
6411-6417. (d) Ghosh, A. K.; Fidanze, S. J. Org. Chem. 1998, 63, 6146-
6152. (e) Spino, C.; Godbout, C. J. Am. Chem. Soc. 2003, 125, 12106-
12107.
1
CHCl3); IR (neat) 3346, 2936, 2823, 1732, 1520 cm-1; H NMR
(400 MHz, CDCl3) δ 7.31-7.38 (m, 5H), 5.08 (s, 2H), 5.04 (s,
1H), 3.68 (br s, 3H), 3.35 (s, 6H), 3.17-3.30 (m, 2H), 2.32 (m,
1H), 2.03 (m, 2H), 1.60-1.90 (m, 5H); 13C NMR (100 MHz,
CDCl3) δ 174.7, 155.2, 136.2, 128.4, 128.0, 127.9, 82.8, 82.0, 66.6,
J. Org. Chem, Vol. 72, No. 20, 2007 7755